Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Axovant Sciences Ltd. | 465,000 | reported | 07 Apr 2017 | tx 1+465,000 |
| REGENERON PHARMACEUTICALS, INC. | 14,349 | reported | 09 Dec 2025 | tx 153+190,654−91,241 |
| CytomX Therapeutics, Inc. | 14,000 | reported | 20 Jun 2017 | tx 2+42,000 |
| SCYNEXIS INC | 9,217 | reported | 02 Jul 2018 | tx 9+106,976 |
| MEDIVATION, INC. | 0 | reported | 28 Sept 2016 | tx 5+121,358−121,899 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Dec 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 1,021 | 701.51 USD | |
| 05 Dec 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 2,476 | 0.00 USD | |
| 08 Dec 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 1,336 | 712.94 USD | |
| 05 Dec 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 12,210 | 0.00 USD | deriv |
| 16 Dec 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 759 | 730.81 USD | |
| 09 Dec 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 274 | 787.00 USD | |
| 06 Dec 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 2,332 | 0.00 USD | |
| 06 Dec 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 8,981 | 0.00 USD | deriv |
| 01 Nov 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 844.61 USD | |
| 01 Nov 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 381.40 USD | |
| 01 Nov 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 0.00 USD | deriv |
| 01 Oct 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 1054.06 USD | |
| 01 Oct 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 381.40 USD | |
| 01 Oct 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 0.00 USD | deriv |
| 03 Sept 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 1178.73 USD | |
| 03 Sept 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 381.40 USD | |
| 03 Sept 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 0.00 USD | deriv |
| 01 Aug 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,137 | 372.46 USD | |
| 01 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,137 | 1060.86 USD | |
| 01 Aug 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,137 | 0.00 USD | deriv |
| 01 Jul 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,137 | 372.46 USD | |
| 01 Jul 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,137 | 1047.11 USD | |
| 01 Jul 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,137 | 0.00 USD | deriv |
| 03 Jun 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,138 | 372.46 USD | |
| 03 Jun 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,138 | 980.16 USD |